Author:
Gui Lin,Xie Zucheng,Zhang Wen,Chen Xinrui,Liu Shaoyan,Wang Xiaolei,Yi Jun-Lin,An Changming,Lu Haizhen,Yao Jiarui,Zhu Haohua,Xie Tongji,Tang Le,He Xiaohui,Shi Yuankai
Reference24 articles.
1. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012;K D Shield;CA Cancer J Clin,2017
2. The natural history of patients with squamous cell carcinoma of the hypopharynx;S F Hall;Laryngoscope,2008
3. Hypopharyngeal cancer: A state of the art review;J C Garneau;Oral Oncol,2018
4. Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group;P Blanchard;J Clin Oncol,2013
5. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study;Eew Cohen;Lancet,2019